Trials / Unknown
UnknownNCT06170216
Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)
A Single-center, Non-interventionary Clinical Study Evaluating the Efficacy and Safety of Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 220 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Describe the application status of different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL), observe the therapeutic efficacy and safety of the treatment modalities.
Detailed description
Evaluated the efficacy and safety of different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | immunochemotherapies | Observing different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL), which are chosen by investigators, such as RCHOP, BR, RCVP, etc. |
Timeline
- Start date
- 2023-01-10
- Primary completion
- 2023-12-19
- Completion
- 2026-01-10
- First posted
- 2023-12-14
- Last updated
- 2024-02-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06170216. Inclusion in this directory is not an endorsement.